CPD, LLC
Records under this name other than the patents CPD, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,893,080 | Method of restoring the incretin effect Formerly held Lapsed on the fee record Ended Feb 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2023 | From the USPTO record |
| US 8,829,018 | Method of restoring the incretin effect Formerly held Lapsed on the fee record Ended Sep 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 9, 2022 | From the USPTO record |
| US 8,785,469 | Method of treating atherogenic dyslipidemia Formerly held Lapsed on the fee record Ended Jul 22, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2022 | From the USPTO record |
| US 9,987,268 | Method of restoring the incretin effect Formerly held Lapsed on the fee record Ended Jun 5, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2022 | From the USPTO record |
| US 8,445,508 | Method of restoring the incretin effect Formerly held Lapsed on the fee record Ended May 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended May 21, 2021 | From the USPTO record |
| US 8,399,474 | Method of restoring the incretin effect Formerly held Lapsed on the fee record Ended Mar 19, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2021 | From the USPTO record |
| US 6,846,831 | Method of treating the syndrome of lipodystrophy Formerly held Term ended Ended no later than Aug 15, 2020 · From the USPTO record | Term ended | Ended no later than Aug 15, 2020 | From the USPTO record |
| US 6,919,310 | Method of treating the syndrome of coronary heart disease risk factors in humans Formerly held Term ended Ended no later than Aug 15, 2020 · From the USPTO record | Term ended | Ended no later than Aug 15, 2020 | From the USPTO record |
| US 6,262,062 | Method of treating the syndrome of coronary heart disease risk factors in humans Formerly held Lapsed on the fee record Ended Jul 17, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2009 | From the USPTO record |
| US 6,026,817 | Method of treating the syndrome of coronary heart disease risk factors in humans Formerly held Lapsed on the fee record Ended Feb 22, 2008 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2008 | From the USPTO record |